Laurus Labs Ltd News
CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%
Thus far in the calendar year 2024 (CY24), the market price of Neuland Laboratories has zoomed 216%, Piramal Pharma (88%), Divi's Labs (53%) and Jubilant Pharmova (52%)
 "CDMO shares under pressure; Neuland, Laurus, Syngene tank up to 12%")
Laurus Labs up 7% on stable sales, better margin guidance for H2 FY25
The company said expectations of a better second half of the current financial year (H2FY25) is based on facility ramp up, delivery of late-phase NCE projects, and Ebitda margins improvement
 "Laurus Labs up 7% on stable sales, better margin guidance for H2 FY25")
Aster DM, Laurus Labs among 5 smallcap stock ideas in a falling market
Eris Lifesciences, BLS International and Five-Star Business are the other 3 smallcap stocks that look favourably placed on the technical charts in an otherwise weak market.
 "Aster DM, Laurus Labs among 5 smallcap stock ideas in a falling market")
Pharma stocks soar 6% as investors respond to double dose of Good News!
Individually, shares of Laurus Labs rose up to 5.55 per cent at Rs 517.90 per share, Akums Drugs and Pharmaceuticals shares locked in 5 per cent upper circuit at Rs 910.55 a piece
 "Pharma stocks soar 6% as investors respond to double dose of Good News!")
F&O stocks in focus: Long buildup seen in Naukri, Voltas, Laurus Labs
Stocks with long buildup in August series: Key levels to track on Voltas, Naukri and Laurus Labs as these stocks could potentially gain up to 9 per cent from present levels.
 "F&O stocks in focus: Long buildup seen in Naukri, Voltas, Laurus Labs")
Healthcare at new high; Lupin, Glenmark among 5 stocks for up to 15% upside
5 breakout pharma stocks: Glenmark, Lupin, Laurus Labs, Dr Lal PathLabs and Zydus Life can potentially rally up to 15 per cent, suggest charts.
 "Healthcare at new high; Lupin, Glenmark among 5 stocks for up to 15% upside")
